Use of the insulin-like-growth factor 1 splice variant MGF for the prevention of myocardial damage

• 收藏
• 分享

专利权人:

Geoffrey Goldspink

发明人:

Geoffrey Goldspink,Paul Goldspink

申请号：

US13624365

公开号：

US09919031B2

申请日:

2012.09.21

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The invention relates to the use of a Mechano Growth Factor (MGF) polypeptide or a polynucleotide encoding an MGF polypeptide in the manufacture of a medicament for the prevention or limitation of myocardial damage in response to ischemia or mechanical overload of the heart by preventing or limiting apoptosis in the myocardium.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/